For example, in neurological diseases such as aging-related Alzheimer disease [38,39] and De Vivo disease/syndrome [40,41], where BBB disruption and GLUT1 defect were clearly observed, the levels of glucose in brain interstitial fluid were decreased from the normal values. This evidence concerns the gene SLC2A1 and Alzheimer disease.